Enzene Biosciences launches Ranibizumab to treat neovascular AMD
Ranibizumab biosimilar is the company’s seventh biosimilar
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Investment in novel therapies key priority to tackle AMR: GlobalData
As per GlobalData Pharmaceutical Intelligence Center’s pipeline drugs database, there are around 929 antibiotics and 182…
Sanjivani Paranteral, Hindustan Antibiotics partner to manufacture IV formulations and IV Sets
The partnership will see the establishment of a manufacturing facility within the premises of Hindustan Antibiotics at Pimpri…
Experts believe gene therapies will disrupt Gaucher disease drug market: GlobalData
Gaucher disease, a rare inherited metabolic disorder caused by defects in the GBA1 gene, results in harmful glucocerebroside…
Strides gets USFDA approval for generic Suprep Bowel Prep Kit
The product belongs to a group of medicines prescribed to those who are required to undergo a colon cleanse prior to a colonoscopy
Lupin launches FDC drug Vilfuro-G for COPD management in India
The launch follows the approval granted by the Drug Controller General of India for the dry powder inhaler (DPI) product
Evive, Acrotech get FDA nod for Ryzneuta (Efbemalenograstim alfa Injection) for chemo-induced…
Neutropenia is characterised by persistently low levels of neutrophils due to the use of chemotherapy and other types of…
Lupin gets US FDA approval for Dapagliflozin tablets and Pitavastatin tablets
Both the products will be manufactured at Lupin’s Pithampur facility in India
Strides gets USFDA approval for Levetiracetam Oral Solution
It is used in the treatment of seizures
Sugemalimab approval in China makes it only second drug approved globally for ENKTL: GlobalData
GlobalData forecasts sugemalimab to generate sales of $31 million (patient-based forecast) by 2030 for T-cell lymphomas in China